Rational design, synthesis, and serine protease inhibitory activity of a novel P1-argininal derivative featuring a conformationally constrained P2–P3 bicyclic lactam moiety
- 4 February 1997
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 7 (3) , 331-336
- https://doi.org/10.1016/s0960-894x(97)00004-8
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Big rigs in blood coagulationNature, 1996
- Crystallographic determination of the structures of human α‐thrombin complexed with BMS‐186282 and BMS‐189090Protein Science, 1996
- Structure-Activity Study of Tripeptide Thrombin Inhibitors Using .alpha.-Alkyl Amino Acids and Other Conformationally Constrained Amino Acid SubstitutionsJournal of Medicinal Chemistry, 1995
- Design of Novel, Nonpeptidic Thrombin Inhibitors and Structure of a Thrombin–Inhibitor ComplexAngewandte Chemie International Edition in English, 1995
- Kinetic and Crystallographic Studies of Thrombin with Ac-(D)Phe-Pro-boroArg-OH and Its Lysine, Amidine, Homolysine, and Ornithine AnalogsBiochemistry, 1995
- The clot thickens: clues provided by thrombin structureTrends in Biochemical Sciences, 1995
- elastase inhibitors containing conformationally restricted lactams as P3-P2 dipeptide replacementsBioorganic & Medicinal Chemistry Letters, 1993
- Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury.Journal of Clinical Investigation, 1989
- Protected lactam-bridged dipeptides for use as conformational constraints in peptidesThe Journal of Organic Chemistry, 1982
- Bioactive Conformation of Luteinizing Hormone-Releasing Hormone: Evidence from a Conformationally Constrained AnalogScience, 1980